BioSpace News Archive

Business

Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update

Wave Life Sciences Ltd., a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced financial results for the third quarter ended September 30, 2019 and provided a business update.

November 5, 2019
·
15 min read
Business

Codexis Reports Third Quarter 2019 Financial Results

Codexis, Inc., a leading protein engineering company, announces financial results for the three and nine months ended September 30, 2019 and provides a business update.

November 5, 2019
·
19 min read
Business

BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the third quarter ended September 30, 2019.

November 5, 2019
·
19 min read
Business

Xenon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Inc., a clinical stage biopharmaceutical company, reported its financial results for the third quarter ended September 30, 2019 and provided a corporate update.

November 5, 2019
·
15 min read
Business

Ultragenyx Reports Third Quarter 2019 Financial Results and Corporate Update

Strong Crysvita® (burosumab) Launch Continues with Approximately 1,130 Patients on Reimbursed Commercial Therapy in the United States as of the end of the Third Quarter

November 5, 2019
·
11 min read
Deals

Neurocrine Biosciences to Present at Upcoming Healthcare Conferences in November 2019

Neurocrine Biosciences, Inc. announced that Neurocrine Biosciences management will present at the following investor conferences

November 5, 2019
·
1 min read
Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics With a $57 Million Series A

Innovative Targeting Solutions (ITS) today announced that, A2 Biotherapeutics, Inc., co-founded in 2018 with Alexander Kamb, former SVP of Research at Amgen Inc., has emerged after operating in stealth mode for the last 18 months.

November 5, 2019
·
2 min read
Business

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2020 ended September 30, 2019 before financial markets open on November 14, 2019.

November 5, 2019
·
2 min read
BioForest

WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System

WaveForm Technologies Inc. a wholly owned subsidiary of AgaMatrix Holdings LLC and developer of novel continuous glucose monitoring products, today announced it has received CE Mark (Conformité Européenne) approval for its Cascade Continuous Glucose Monitoring (CGM) system.

November 5, 2019
·
6 min read
Pharm Country

The American Journal of Managed Care® Releases Agenda for 2019 Patient-Centered Oncology Care® Meeting

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, announced the agenda for the Patient-Centered Oncology Care® (PCOC) meeting that will take place on Nov. 8 at the Sofitel Philadelphia at Rittenhouse Square.

November 5, 2019
·
2 min read